Literature DB >> 18193078

Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.

H Kiriazis1, K Wang, Q Xu, X-M Gao, Z Ming, Y Su, X-L Moore, G Lambert, M E Gibbs, A M Dart, X-J Du.   

Abstract

BACKGROUND AND
PURPOSE: The role of beta-adrenoceptors in heart disease remains controversial. Although beta-blockers ameliorate the progression of heart disease, the mechanism remains undefined. We investigated the effect of beta-adrenoceptors on cardiac hypertrophic growth using beta(1)- and beta(2)-adrenoreceptor knockout and wild-type (WT) mice. EXPERIMENTAL APPROACH: Mice were subjected to aortic banding or sham surgery, and their cardiac function was determined by echocardiography and micromanometry. KEY
RESULTS: At 4 and 12 weeks after aortic banding, the left ventricle:body mass ratio was increased by 80-87% in wild-type mice, but only by 15% in knockouts, relative to sham-operated groups. Despite the blunted hypertrophic growth, ventricular function in knockouts was maintained. WT mice responded to pressure overload with up-regulation of gene expression of inflammatory cytokines and fibrogenic growth factors, and with severe cardiac fibrosis. All these effects were absent in the knockout animals. CONCLUSION AND IMPLICATIONS: Our findings of a markedly attenuated cardiac hypertrophy and fibrosis following pressure overload in this knockout model emphasize that beta-adrenoceptor signalling plays a central role in cardiac hypertrophy and maladaptation following pressure overload.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193078      PMCID: PMC2259198          DOI: 10.1038/sj.bjp.0707622

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression.

Authors:  D R Murray; S D Prabhu; B Chandrasekar
Journal:  Circulation       Date:  2000-05-23       Impact factor: 29.690

2.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

Authors:  J W Knowles; G Esposito; L Mao; J R Hagaman; J E Fox; O Smithies; H A Rockman; N Maeda
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis.

Authors:  X J Du; D J Autelitano; R J Dilley; B Wang; A M Dart; E A Woodcock
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

4.  Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency.

Authors:  A Jalil; M Horiuchi; M Nomoto; K Kobayashi; T Saheki
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

5.  Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors.

Authors:  D K Rohrer; A Chruscinski; E H Schauble; D Bernstein; B K Kobilka
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

6.  Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy.

Authors:  T Ohtsuka; M Hamada; G Hiasa; O Sasaki; M Suzuki; Y Hara; Y Shigematsu; K Hiwada
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

7.  Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level.

Authors:  S B Liggett; N M Tepe; J N Lorenz; A M Canning; T D Jantz; S Mitarai; A Yatani; G W Dorn
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

8.  Adverse consequences of high sympathetic nervous activity in the failing human heart.

Authors:  D M Kaye; J Lefkovits; G L Jennings; P Bergin; A Broughton; M D Esler
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

9.  Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart.

Authors:  R S Farivar; D C Crawford; A V Chobanian; P Brecher
Journal:  Hypertension       Date:  1995-04       Impact factor: 10.190

10.  Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression.

Authors:  M Iwase; S P Bishop; M Uechi; D E Vatner; R P Shannon; R K Kudej; D C Wight; T E Wagner; Y Ishikawa; C J Homcy; S F Vatner
Journal:  Circ Res       Date:  1996-04       Impact factor: 17.367

View more
  15 in total

Review 1.  Inflammation and therapy for hypertension.

Authors:  Cheryl L Laffer; Fernando Elijovich
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

2.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

3.  Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes.

Authors:  Mingming Zhao; Giovanni Fajardo; Takashi Urashima; Joshua M Spin; Sara Poorfarahani; Viswanathan Rajagopalan; Diem Huynh; Andrew Connolly; Thomas Quertermous; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

Review 4.  Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.

Authors:  Brian C Jensen; Timothy D O'Connell; Paul C Simpson
Journal:  J Mol Cell Cardiol       Date:  2010-11-28       Impact factor: 5.000

5.  Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.

Authors:  Q Xu; A Dalic; L Fang; H Kiriazis; R H Ritchie; K Sim; X-M Gao; G Drummond; M Sarwar; Y-Y Zhang; A M Dart; X-J Du
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

6.  A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway.

Authors:  Qian Yin; Haiyan Lu; Yajun Bai; Aiju Tian; Qiuxiang Yang; Jimin Wu; Chengzhi Yang; Tai-Ping Fan; Youyi Zhang; Xiaohui Zheng; Xiaopu Zheng; Zijian Li
Journal:  Br J Pharmacol       Date:  2015-05-05       Impact factor: 8.739

7.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

8.  Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction.

Authors:  ByungSu Yoo; Anthony Lemaire; Supachoke Mangmool; Matthew J Wolf; Antonio Curcio; Lan Mao; Howard A Rockman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-24       Impact factor: 4.733

9.  Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.

Authors:  Helen Kiriazis; Niquita Tugiono; Qi Xu; Xiao-Ming Gao; Nicole L Jennings; Ziqui Ming; Yidan Su; Paul Klenowski; Roger J Summers; Alberto Kaumann; Peter Molenaar; Xiao-Jun Du
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  Lamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice.

Authors:  Ivana Gotic; Michael Leschnik; Ursula Kolm; Mato Markovic; Bernhard J Haubner; Katarzyna Biadasiewicz; Bernhard Metzler; Colin L Stewart; Roland Foisner
Journal:  Circ Res       Date:  2009-11-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.